These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6201917)
21. A T cell epitope for experimental allergic neuritis. Olee T; Powers JM; Brostoff SW J Neuroimmunol; 1988 Aug; 19(1-2):167-73. PubMed ID: 2456303 [TBL] [Abstract][Full Text] [Related]
22. Multiple encephalitogenic peptides of myelin basic protein in A.CA mice. Rajan AJ; Cross AH; Raine CS; Diamond B Cell Immunol; 1993 Apr; 147(2):378-87. PubMed ID: 7680964 [TBL] [Abstract][Full Text] [Related]
23. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. Mor F; Cohen IR J Immunol; 1995 Oct; 155(7):3693-9. PubMed ID: 7561070 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673 [TBL] [Abstract][Full Text] [Related]
25. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Mao YS; Lu CZ; Wang X; Xiao BG Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406 [TBL] [Abstract][Full Text] [Related]
26. Conformation of an antigenic determinant for experimental autoimmune neuritis. Shin HC; Stuart B; McFarlane EF Biochem Biophys Res Commun; 1996 Jul; 224(1):5-9. PubMed ID: 8694832 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis. Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961 [TBL] [Abstract][Full Text] [Related]
28. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides. Vandenbark AA; Vainiene M; Celnik B; Hashim GA; Buenafe A; Offner H J Immunol; 1994 Jul; 153(2):852-61. PubMed ID: 7517426 [TBL] [Abstract][Full Text] [Related]
29. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration. Pilartz M; Jess T; Indefrei D; Schröder JM Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapy of autoimmune disease with synthetic peptides. Metzler B; Wraith DC Immunol Today; 1994 Feb; 15(2):91. PubMed ID: 7512343 [No Abstract] [Full Text] [Related]
31. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455 [TBL] [Abstract][Full Text] [Related]
32. Cell-mediated immunity to bovine P2 protein and neuritogenic synthetic peptide in experimental allergic neuritis. Nomura K; Hamaguchi K; Ohno R; Hosokawa T; Negishi T; Yamashita T; Suzuki M; Uyemura K J Neuroimmunol; 1987 May; 15(1):25-35. PubMed ID: 2437152 [TBL] [Abstract][Full Text] [Related]
33. Neuritogenic determinant of bovine P2 protein in peripheral nerve myelin. Uyemura K; Suzuki M; Kitamura K; Horie K; Ogawa Y; Matsuyama H; Nozaki S; Muramatsu I J Neurochem; 1982 Sep; 39(3):895-8. PubMed ID: 6178804 [TBL] [Abstract][Full Text] [Related]
34. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats. Araga S; Kishimoto M; Doi S; Nakashima K J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. Stepaniak JA; Gould KE; Sun D; Swanborg RH J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385 [TBL] [Abstract][Full Text] [Related]
36. Experimental allergic neuritis and Guillain-Barré syndrome: immune mechanisms. A short review. Hartung HP Acta Neurol Belg; 1994; 94(2):120-3. PubMed ID: 8036878 [No Abstract] [Full Text] [Related]
37. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363 [TBL] [Abstract][Full Text] [Related]
38. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118 [TBL] [Abstract][Full Text] [Related]
39. Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis. Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T J Immunol; 1998 Jan; 160(2):681-90. PubMed ID: 9551903 [TBL] [Abstract][Full Text] [Related]
40. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]